Shane William Charles Kovacs is Ch. Operating & Financial Off. of Olema Pharmaceuticals, Inc.. Currently has a direct ownership of 510,458 shares of OLMA, which is worth approximately $4.02 Million. The most recent transaction as insider was on Nov 15, 2024, when has been sold 25,000 shares (Common Stock) at a price of $7.02 per share, resulting in proceeds of $175,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 510K
5.25% 3M change
20.11% 12M change
Total Value Held $4.02 Million

Shane William Charles Kovacs Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 15 2024
BUY
Exercise of conversion of derivative security
$175,500 $7.02 p/Share
25,000 Added 4.67%
510,458 Common Stock
Jan 12 2024
BUY
Exercise of conversion of derivative security
$351,000 $7.02 p/Share
50,000 Added 9.35%
484,987 Common Stock
Dec 12 2023
BUY
Exercise of conversion of derivative security
$70,200 $7.02 p/Share
10,000 Added 2.25%
434,987 Common Stock
Nov 22 2023
SELL
Open market or private sale
$127,024 $13.89 p/Share
9,145 Reduced 2.11%
424,987 Common Stock
Nov 21 2023
SELL
Open market or private sale
$144,434 $15.05 p/Share
9,597 Reduced 2.16%
434,132 Common Stock
Nov 20 2023
BUY
Grant, award, or other acquisition
-
36,750 Added 7.65%
443,729 Common Stock
Apr 06 2023
BUY
Open market or private purchase
-
10,000 Added 2.46%
396,197 Common Stock
Sep 02 2022
BUY
Open market or private purchase
-
20,000 Added 4.99%
381,197 Common Stock
Jun 15 2020
BUY
Grant, award, or other acquisition
-
358,680 Added 50.0%
358,680 Common Stock
SWC

Shane William Charles Kovacs

Ch. Operating & Financial Off.
San Francisco, CA

Track Institutional and Insider Activities on OLMA

Follow Olema Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OLMA shares.

Notify only if

Insider Trading

Get notified when an Olema Pharmaceuticals, Inc. insider buys or sells OLMA shares.

Notify only if

News

Receive news related to Olema Pharmaceuticals, Inc.

Track Activities on OLMA